Diana Brixner
- Family Practice top 1%
- Medication Adherence and Compliance 15
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes 11
- Internal Medicine top 5%
-
- Diabetes Treatment and Management 24
- Diabetes Management and Research 22
-
- Blood Pressure and Hypertension Studies 8
-
- Health Systems, Economic Evaluations, Quality of Life 38
- Pharmaceutical Economics and Policy 20
-
- Pharmaceutical studies and practices 13
- Co-authors
- Joseph BiskupiakCarrie McAdam‐MarxGary M. OderdaXiangyang YeSameer R. GhateA. KeskinaslanDavid D. StenehjemSudhir Unni
- Journals
- Journal of Managed Care & Specialty Pharmacy (19 papers)Value in Health (13 papers)Current Medical Research and Opinion (5 papers)
- Partner nations
- United StatesGermanyAustria
In The Last Decade
Diana Brixner
166 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 141
- Family Practice 250
- Geriatrics and Gerontology 208
- Internal Medicine 97
- Endocrinology, Diabetes and Metabolism 329
- Cardiology and Cardiovascular Medicine 450
Countries citing papers authored by Diana Brixner
This map shows the geographic impact of Diana Brixner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Brixner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Brixner more than expected).
Fields of papers citing papers by Diana Brixner
This network shows the impact of papers produced by Diana Brixner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Brixner. The network helps show where Diana Brixner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Diana Brixner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 1 | |
| 6 | 2019 | 43 | |
| 7 | Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation | 2018 | 0 |
| 8 | 2018 | 67 | |
| 9 | 2018 | 13 | |
| 10 | 2017 | 12 | |
| 11 | Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation. | 2016 | 31 |
| 12 | 2015 | 1 | |
| 13 | 2014 | 0 | |
| 14 | 2013 | 4 | |
| 15 | 2012 | 17 | |
| 16 | Health Resource Utilization and Direct Costs Associated with Angina for Patients with Coronary Artery Disease in a US Managed Care Setting. | 2011 | 24 |
| 17 | 2011 | 11 | |
| 18 | 2010 | 16 | |
| 19 | Cost-effectiveness of insulin analogs. | 2008 | 19 |
| 20 | Managed care's response to a pharmacoeconomic model of serotonin reuptake inhibitors | 2005 | 4 |
About Diana Brixner
Diana Brixner is a scholar working on Family Practice, Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Issues, ethics and legal aspects, having authored 174 papers that have together received 2.7k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (38 papers), Diabetes Treatment and Management (24 papers), Diabetes Management and Research (22 papers), Pharmaceutical Economics and Policy (20 papers), Medication Adherence and Compliance (15 papers), Pharmaceutical studies and practices (13 papers), Pharmaceutical Practices and Patient Outcomes (11 papers) and Blood Pressure and Hypertension Studies (8 papers). The work is most often cited by research in Family Practice (250 citations), Geriatrics and Gerontology (208 citations), Internal Medicine (97 citations), Endocrinology, Diabetes and Metabolism (329 citations) and Cardiology and Cardiovascular Medicine (450 citations). Diana Brixner has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Joseph Biskupiak, Carrie McAdam‐Marx, Gary M. Oderda, Xiangyang Ye, Sameer R. Ghate, A. Keskinaslan, David D. Stenehjem, Sudhir Unni, Sunanda V. Kane and Lisa J. McGarry. Their work appears in journals such as Journal of Managed Care & Specialty Pharmacy, Value in Health, Current Medical Research and Opinion, Clinical Therapeutics and Annals of Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.